Mark J. Murray
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark J. Murray
Mark J. Murray is recorded as CEO at Arbutus Biopharma Corp (ABUS). The proxy statement of Arbutus Biopharma Corp reports total compensation of $3,780,430 for Mark J. Murray in fiscal 2019, including a base salary of $273,491. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Arbutus Biopharma Corp
Other people whose current roles at this company are on record from its filings.
- Lindsay Androski CEO, Chairman, Board Member
- Michael J. McElhaugh CEO, COO, Board Member
- Tuan Nguyen CFO
- Michael McElhaugh COO
- Mike McElhaugh COO
- J. Christopher Naftzger General Counsel
- Anuj Hasija Board Member
- Eric Venker, M.D., Pharm.D. Board Member
- Frank Torti, M.D. Board Member
- Joseph Bishop Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Arbutus Biopharma Corp (ABUS) | Former President and Chief Executive Officer | $273,491 | $3,780,430 |
| 2018 | Arbutus Biopharma Corp (ABUS) | Former President and Chief Executive Officer | $556,000 | $2,527,885 |
Recent activity
No call appearances or filed executive changes recorded yet.